跳至主要内容
临床试验/DRKS00022026
DRKS00022026招募中2 期

Dissemination of tumor cells during minimally invasive and open pancreatic cancer surgery - Domino-Pac

niversitätsklinikum Heidelberg0 个研究点目标入组 90 人开始时间: 2020年5月25日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • newly diagnosed, resectable or borderline resectable1 pancreatic cancer without arterial involvement, on cross-sectional imaging (contrast enhanced CT scan) according to the International Study Group of Pancreatic Surgery (ISGPS) criteria; =18 and =85 years of age; capacity to informed consent; written informed consent; Eastern Cooperative Oncology Group (ECOG) performance status 0-2; patient considered to tolerate surgery

排除标准

  • distant metastatic disease; neoadjuvant chemotherapy/radiotherapy; American Society of Anesthesiologists (ASA) score > III; history of another malignancy in the past 5 years; inability to comply with study and/or follow-up procedures; (language) problems in understanding the patient information document explaining the present clinical trial; any condition which could result in an undue risk for the patient in the opinion of the investigator

研究者

发起方
niversitätsklinikum Heidelberg

相似试验